ACE and kidney disorder: Pharmacological strategies for slowing down the progression of kidney disease involve the use of drugs such as angiotensin-converting enzyme inhibitors (ACEi), angiotensin receptor blockers (ARB), and sodium-glucose transporter-2 inhibitors (SGLT-2i) to reduce proteinuria and retard the progression of kidney disease.